keyword
https://read.qxmd.com/read/38674921/l-carnitine-in-the-treatment-of-psychiatric-and-neurological-manifestations-a-systematic-review
#1
REVIEW
Wenbo Wang, Da Pan, Qi Liu, Xiangjun Chen, Shaokang Wang
OBJECTIVE: L-carnitine (LC), a vital nutritional supplement, plays a crucial role in myocardial health and exhibits significant cardioprotective effects. LC, being the principal constituent of clinical-grade supplements, finds extensive application in the recovery and treatment of diverse cardiovascular and cerebrovascular disorders. However, controversies persist regarding the utilization of LC in nervous system diseases, with varying effects observed across numerous mental and neurological disorders...
April 20, 2024: Nutrients
https://read.qxmd.com/read/38674918/effects-of-gluten-on-gut-microbiota-in-patients-with-gastrointestinal-disorders-migraine-and-dermatitis
#2
RANDOMIZED CONTROLLED TRIAL
Ismael San Mauro Martín, Sara López Oliva, Elena Garicano Vilar, Guerthy Melissa Sánchez Niño, Bruno F Penadés, Ana Terrén Lora, Sara Sanz Rojo, Luis Collado Yurrita
As gluten may trigger gastrointestinal disorders (GIDs), its presence or absence in the diet can change the diversity and proportion of gut microbiota. The effects of gluten after six weeks of a double-blind, placebo-controlled intervention with a gluten-free diet (GFD) were studied in participants with GIDs suffering from migraines and atopic dermatitis (n = 46). Clinical biomarkers, digestive symptoms, stool, the Migraine Disability Assessment questionnaire, and zonulin levels were analyzed. Next-generation sequencing was used to amplify the 16S rRNA gene of bacteria and the internal transcribed spacer (ITS) regions of fungi...
April 20, 2024: Nutrients
https://read.qxmd.com/read/38669638/efficacy-and-safety-of-erenumab-in-participants-with-episodic-migraine-in-whom-2-4-prior-preventive-treatments-had-failed-liberty-3-year-study
#3
RANDOMIZED CONTROLLED TRIAL
Uwe Reuter, Peter J Goadsby, Michel D Ferrari, Gabriel Paiva Da Silva Lima, Subhayan Mondal, Jawed Kalim, Fatima Hasan, Shihua Wen, Michal Arkuszewski, Shaloo Pandhi, Tracy Stites, Michel Lanteri-Minet
BACKGROUND AND OBJECTIVES: The LIBERTY study assessed the efficacy and safety of erenumab in participants with episodic migraine (EM) and 2-4 prior preventive treatment failures. The results have been presented after 3 years of erenumab exposure in its open-label extension phase (OLEP). METHODS: Participants completing the 12-week double-blind treatment phase (DBTP) of the LIBERTY study could enter the OLEP and receive 140 mg of erenumab once monthly for 3 years...
May 2024: Neurology
https://read.qxmd.com/read/38668603/reducing-the-impact-of-headache-and-allodynia-score-in-chronic-migraine-an-exploratory-analysis-from-the-real-world-effectiveness-of-anti-cgrp-monoclonal-antibodies-compared-to-onabotulinum-toxin-a-ramo-study
#4
MULTICENTER STUDY
Danilo Antonio Montisano, Riccardo Giossi, Mattia Canella, Claudia Altamura, Marilena Marcosano, Fabrizio Vernieri, Alberto Raggi, Licia Grazzi
BACKGROUND: Chronic migraine (CM) is a disabling and hard-to-treat condition, associated with high disability and high cost. Among the preventive treatments, botulinum toxin A (BoNT-a) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) are the only disease-specific ones. The assessment of the disease burden is complex, and among others, tools such as the allodynia symptoms checklist (ASC-12) and headache impact test (HIT-6) are very useful. This exploratory study analysed the impact of these two therapies on migraine burden...
April 7, 2024: Toxins
https://read.qxmd.com/read/38666648/effects-of-chronic-pain-diagnoses-on-the-antidepressant-efficacy-of-transcranial-magnetic-stimulation
#5
JOURNAL ARTICLE
Houtan Totonchi Afshar, Joel N Fishbein, Erica J Martinez, Gage M Chu, Mohammad A Shenasa, Dhakshin Ramanathan, Matthew S Herbert
OBJECTIVE: Major depressive disorder (MDD) and chronic pain are highly comorbid and bidirectionally related. Repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex is effective in treating MDD, but additional research is needed to determine if chronic pain interferes with rTMS for MDD. METHODS: Participants were 124 veterans (Mage = 49.14, SD = 13.83) scheduled for 30 sessions of rTMS across six weeks. Depression severity was monitored weekly using the Patient Health Questionnaire-9...
April 26, 2024: Psychosomatic Medicine
https://read.qxmd.com/read/38664605/real-world-effectiveness-and-satisfaction-with-intravenous-eptinezumab-treatment-in-patients-with-chronic-migraine-review-an-observational-multi-site-us-based-study
#6
MULTICENTER STUDY
Charles Argoff, Steven P Herzog, Ryan M Smith, Sameer V Kotak, Liza Sopina, Yvonna Saltarska, Seema Soni-Brahmbhatt, Fawad A Khan
BACKGROUND: Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled nature of randomized trials in migraine prevention, many real-world patients with comorbidities or prior exposure to certain therapies are excluded. Capturing evidence of the effectiveness of treatment in real-world clinical settings can further shape treatment paradigms. The objective of this study was to develop a comprehensive understanding of both patients' and physicians' real-world experiences with eptinezumab for chronic migraine (CM)...
April 25, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38663979/identification-and-characterization-of-migraine-in-pregnancy-a-norwegian-registry-based-cohort-study
#7
JOURNAL ARTICLE
Vera R Mitter, Angela Lupattelli, Marte-Helene Bjørk, Hedvig M E Nordeng
BACKGROUND: Migraine is common in women of reproductive age. Migraine's episodic manifestation and acute and preventive pharmacological treatment options challenge studying drug safety for this condition during pregnancy. To improve such studies, we aimed to develop algorithms to identify and characterize migraines in electronic healthcare registries and to assess the level of care. METHODS: We linked four registries to detect pregnancies from 2009-2018 and used three algorithms for migraine identification: i) diagnostic codes, ii) triptans dispensed, and iii) a combination of both...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38663908/candespartan-study-candesartan-spanish-response-prediction-and-tolerability-study-in-migraine
#8
MULTICENTER STUDY
David García-Azorín, Cristina Martínez-Badillo, Javier Camiña Muñiz, Ana Beatriz Gago-Veiga, Noemi Morollón Sánchez, Vicente González-Quintanilla, Jesús Porta-Etessam, Alvaro Sierra-Mencía, Nuria González-García, Yésica González-Osorio, Marcos Polanco-Fernandez, Andrea Recio-García, Robert Belvis Nieto, Angel Luis Guerrero-Peral
INTRODUCTION: Effectiveness of candesartan in migraine prevention is supported by two randomized controlled trials. We aimed to assess the effectiveness, tolerability, and response predictors of candesartan in the preventive treatment of migraine. METHODS: Observational, multicenter, prospective cohort study. The 50%, 75% and 30% responder rates, between weeks 8-12 and 20-24, were compared with the baseline. Treatment emergent adverse effects were systematically evaluated...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38663902/physical-impairment-during-and-between-migraine-attacks-a-daily-diary-study-of-patients-with-chronic-migraine
#9
JOURNAL ARTICLE
David J Whitaker, Gina M Dumkrieger, Joseph G Hentz, David W Dodick, Todd J Schwedt
OBJECTIVE: While a substantial body of research describes the disabling impacts of migraine attacks, less research has described the impacts of migraine on physical functioning between migraine attacks. The objective of this study is to describe physical impairment during and between migraine attacks as a dimension of burden experienced by people living with chronic migraine. METHODS: The physical impairment domain of the Migraine Physical Function Impact Diary was recorded in headache diaries from the Medication Overuse Treatment Strategy trial...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38662902/an-update-on-migraine-current-and-new-treatment-options
#10
REVIEW
Teddy Hervias
Migraine headache is a common and potentially debilitating disorder often treated by physician associates/assistants (PAs) and other providers. With the recent advances in new drugs and device technology for the treatment of migraine, the American Headache Society has released a consensus statement on both preventive and acute strategies for clinical practice. The US FDA has recently approved various types of medications and devices for the treatment and prevention of migraine attacks including several calcitonin gene-related peptide (CGRP) receptor inhibitors, a selective serotonin receptor agonist (SSRA), noninvasive vagus nerve stimulation (nVNS), external trigeminal nerve stimulation (e-TNS), and external concurrent occipital and trigeminal neurostimulation (eCOT-NS), among other pharmacologic and nonpharmacologic options...
May 1, 2024: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/38660093/prognostic-significance-vestibular-examination-results-in-patients-with-vestibular-migraine
#11
JOURNAL ARTICLE
Fumiyuki Goto, Koichiro Wasano, Shoji Kaneda, Kenji Okami
INTRODUCTION: Vestibular migraine (VM) is a newly defined clinical condition. Several vestibular abnormalities have been reported in patients with VM. However, to date, no specific vestibular examinations are used to define VM. Therefore, the utility of vestibular examinations is limited. Currently, the role of vestibular examination has not been clearly defined. We speculated that the results of vestibular examinations could predict the prognosis of VM. We investigated the relationship between the vestibular examination results and clinical outcomes in patients with VM...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38659334/a-multicenter-open-label-long-term-safety-study-of-rimegepant-for-the-acute-treatment-of-migraine
#12
MULTICENTER STUDY
Robert Croop, Gary Berman, David Kudrow, Kathleen Mullin, Alexandra Thiry, Meghan Lovegren, Gilbert L'Italien, Richard B Lipton
BACKGROUND: The present study evaluated the long-term safety and tolerability of rimegepant, an orally administered small molecule calcitonin gene-related peptide receptor antagonist, in people with migraine. METHODS: This multicenter, long-term, open-label safety study included adults (≥18 years) with ≥1 year history of migraine who were sequentially enrolled into three groups: participants in the first two groups had either 2-8 or 9-14 moderate to severe migraine attacks per month by history and treated as needed ( pro re nata [PRN]) with one rimegepant 75 mg oral tablet up to once per calendar day for 52 weeks (PRN 2-8 and PRN 9-14); a third group, included to collect safety data during higher-frequency dosing, had 4-14 moderate to severe migraine attacks per month by history and who took one rimegepant tablet every other day as scheduled dosing plus PRN dosing of one rimegepant tablet for migraine attacks of any severity on nonscheduled dosing days for 12 weeks (every other day (EOD) + PRN)...
April 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38658853/female-selective-mechanisms-promoting-migraine
#13
REVIEW
Shagun Singh, Caroline M Kopruszinski, Moe Watanabe, David W Dodick, Edita Navratilova, Frank Porreca
Sexual dimorphism has been revealed for many neurological disorders including chronic pain. Prelicinal studies and post-mortem analyses from male and female human donors reveal sexual dimorphism of nociceptors at transcript, protein and functional levels suggesting different mechanisms that may promote pain in men and women. Migraine is a common female-prevalent neurological disorder that is characterized by painful and debilitating headache. Prolactin is a neurohormone that circulates at higher levels in females and that has been implicated clinically in migraine...
April 24, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38656579/influence-of-role-expectancy-on-patient-reported-outcomes-among-patients-with-migraine-a-randomized-clinical-trial
#14
RANDOMIZED CONTROLLED TRIAL
Arne May, Gabriela F Carvalho, Annika Schwarz, Hauke Basedau
IMPORTANCE: It is usually assumed that an individual's classification as a patient or a healthy person is determined by the presence or absence of disease, but little is known about whether the mere awareness of being a patient or a healthy control can play an important role for reporting outcomes. OBJECTIVE: To investigate whether assignment to the role of a patient or a healthy control has an effect on patient-reported outcomes. DESIGN, SETTING, AND PARTICIPANTS: This single center, double-blind, 3-group randomized clinical trial included consecutive patients from a tertiary headache clinic based at a single center in Germany who were invited to participate between October 2019 and June 2023...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38655598/dihydroergotamine-mesylate-nasal-spray-an-acute-treatment-option-for-migraine-in-adults
#15
REVIEW
Marcello Silvestro, Ilaria Orologio, Alessandro Tessitore, Francesca Trojsi, Gioacchino Tedeschi, Antonio Russo
INTRODUCTION: Although the landscape of migraine symptomatic treatment has been enriched by novel effective drugs, it is mandatory to critically reappraise older molecules to ascertain whether they could still represent reliable alternatives in specific endophenotypes of patients or migraine attacks. Among these, dihydroergotamine (DHE) nasal spray has been shown to be effective and is characterized by greater tolerability and manageability than the parenteral DHE formulation. AREAS COVERED: In this narrative review, the authors describe the pharmacodynamic and pharmacokinetic properties of DHE nasal spray and explore the results of the trials which explored its efficacy, safety and tolerability as migraine symptomatic treatment...
April 24, 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38654177/trends-and-prescribing-patterns-of-antimigraine-medicines-in-nine-major-cities-in-china-from-2018-to-2022-a-retrospective-prescription-analysis
#16
JOURNAL ARTICLE
Jing Huang, Xinwei Wang, Yiyi Jin, Guodong Lou, Zhenwei Yu
BACKGROUND: The objective of this study was to investigate the trends and prescribing patterns of antimigraine medicines in China. METHODS: The prescription data of outpatients diagnosed with migraine between 2018 and 2022 were extracted from the Hospital Prescription Analysis Cooperative Project of China. The demographic characteristics of migraine patients, prescription trends, and corresponding expenditures on antimigraine medicines were analyzed. We also investigated prescribing patterns of combination therapy and medicine overuse...
April 23, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38653889/changes-in-physiological-traits-gene-expression-and-phytochemical-profile-of-mentha-piperita-in-response-to-elicitor
#17
JOURNAL ARTICLE
Soheila Afkar, Ghasem Karimzadeh
Peppermint (Mentha piperita) is a perennial medicinal plant containing active ingredients that can be used for treating liver and prostate cancers, acute respiratory infections, allergies, digestive problems, neuralgia, and migraines. The objective of this research is to investigate the expression of essential genes in the menthol pathway of Mentha piperita, including Pulegone reductase (Pr), Menthofuran synthase (Mfs), and limonene synthase (Ls) using qPCR, physiological analysis and essential oil composition in response to methyl jasmonate (MeJA) (0...
April 23, 2024: Biochemical Genetics
https://read.qxmd.com/read/38651363/reliability-validity-and-responsiveness-of-the-arabic-version-of-hit-6-questionnaire-in-patients-with-migraine-indicated-for-preventive-therapy-a-multi-center-study
#18
JOURNAL ARTICLE
Mona Hussein, Amr Hassan, Mona A F Nada, Zeinab Mohammed, Nawal F Abdel Ghaffar, Hanaa Kedah, Wael Fathy, Rehab Magdy
BACKGROUND: The Headache Impact Test (HIT-6) is an important patient-reported outcome measure (PROM) in migraine prevention trials. OBJECTIVES: This study aimed to (i) assess the reliability and validity of the Arabic version of HIT-6 in Arabic-speaking patients experiencing migraine, and (ii) evaluate the responsiveness of HIT-6 following migraine preventive therapy. METHODS: In this prospective study, patients with migraine (n = 145) were requested to fill out a headache diary, the Arabic version of HIT-6, and Migraine Disability Assessment Scale (MIDAS) at two time points (baseline and 3 months after initiation of prophylactic treatment)...
April 23, 2024: Headache
https://read.qxmd.com/read/38649822/unsatisfactory-response-to-acute-medications-does-not-affect-the-medication-overuse-headache-development-in-pediatric-chronic-migraine
#19
JOURNAL ARTICLE
Ilaria Frattale, Michela Ada Noris Ferilli, Fabiana Ursitti, Giorgia Sforza, Gabriele Monte, Martina Proietti Checchi, Samuela Tarantino, Luigi Mazzone, Massimiliano Valeriani, Laura Papetti
BACKGROUND: Chronic migraine (CM) negatively impacts the quality of life of 2 to 4% of pediatric patients. In adults, CM is frequently linked to medication overuse headache (MOH), but there is a much lower prevalence of MOH in children. A suboptimal response to acute therapies may lead to their reduced use, thus preventing MOH development in children and adolescents. The frequency of patients with CM who do not respond to acute therapies was examined in the present study. We investigated whether the prevalence of MOH was different between responders and non-responders...
April 23, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38649209/possible-mechanisms-of-auricular-acupoint-stimulation-in-the-treatment-of-migraine-by-activating-auricular-vagus-nerve
#20
JOURNAL ARTICLE
Hao-Han Zhu, Pei-Jing Rong, Yu Chen, Xing-Ke Song, Jun-Ying Wang
Under the guidance of traditional Chinese medicine theory, the clinical research of auricular acupoint stimulation in the treatment of migraine has gained a lot, and the curative efficacy is definite, but its mechanism remains unclear. In the present paper, we discussed the efficacy of auricular acupoint stimulation including "transcutaneous auricular vagus nerve stimulation" (taVNS) in the treatment of migraine in recent years. Through bibliometric analysis, we screened out top 10 auricular acupoints (Shenmen[TF4 ], Pizhixia[AT4 ], Jiaogan[AH6a ], Gan[CO12 ], Yidan[CO11 ], Neifenmi[CO18 ], Shen[CO10 ], Nie[AT2 ], Zhen[AT3 ] and E[AT1 ]) which were the most frequently used for migraine...
April 25, 2024: Zhen Ci Yan Jiu, Acupuncture Research
keyword
keyword
83412
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.